An ARS-Based, Interactive Session Focused on the Patient with T2D Who Requires Pan-Glycemic (FPG and PPG) Control, is Averse to Multiple Daily Injections, and Needs to Lose Weight and Improve Overall HA1c Levels
Published
June 28, 2017
Created by
Related Presenters
Endocrinology, Diabetes and Metabolism
Clinical Assistant Professor of Medicine
University of California, San Diego
President and Principal Investigator
National Research Institute